SYF7d079c7e9b914f6cb3675aba6828fed4Registry ID: 2024-514491-40-00|RecruitingPhase 2
Macrophage imaging GCA
[18F]fluor-PEG-folate PET/CT imaging in giant cell arteritis: a pilot study
Universitair Medisch Centrum Groningen
Loading search results
[18F]fluor-PEG-folate PET/CT imaging in giant cell arteritis: a pilot study
interventional
N/A
1 country
2
Primary Objective: to evaluate arterial [18F]fluor-PEG-folate uptake on PET/CT in patients with active, large vessel GCA; and in the same patients after 9 months of standard treatment.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
Not reported
Date not reportedClick on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
September 2, 2024
Actual (reported)Arterial [18F]fluor-PEG-folate uptake on PET/CT in patients with active, large vessel GCA; and in the same patients after 9 months of standard treatment.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Amsterdam University Medical Center, VUmc Boelelaan
Amsterdam, 1081 HV, Netherlands
Universitair Medisch Centrum Groningen
Groningen, 9700 RB, Netherlands
K.S.M. van der Geest
First Submitted
September 2, 2024
Download the complete CTIS (EMA) record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: European Medicines Agency (EMA), Clinical Trials Information System (CTIS). Original record and public documents are available on CTIS.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved:
Evaluation of Tocilizumab as an add-on Therapy to Corticoids in Giant Cell Arteritis: Proof of Concept Study.